Literature DB >> 11134918

A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression.

S Simpson1, R Corney, P Fitzgerald, J Beecham.   

Abstract

OBJECTIVES: To examine the effectiveness and cost-effectiveness of short-term counselling in general practice for patients with chronic depression or combined depression and anxiety, compared with general practitioner (GP) care alone.
DESIGN: A randomised controlled trial and economic evaluation with an initial assessment at randomisation and follow-ups at 6 and 12 months.
SETTING: Nine general practices that were well-established participants of the Derbyshire counselling in general practice scheme, and already had a counsellor in the practice team.
SUBJECTS: Patients were screened at GP practices, and asked to participate if they scored >/= 14 on the Beck Depression Inventory (BDI), had suffered depression or depression/anxiety for 6 months or more, were aged 18-70 and had no history of drug or alcohol abuse, psychoses or suicidal tendencies.
INTERVENTIONS: The experimental group received usual GP treatment and were also referred to an experienced, well-qualified counsellor attached to their general practice. Of the eight counsellors, two practiced cognitive behavioural therapy (CBT) and six had a psychodynamic approach. The controls were referred back to their GP for routine treatment. There were no restrictions regarding the treatment that could be used, except that GPs could not refer controls to practice counsellors. OUTCOME MEASURES: The main outcome measure was the BDI. Others included the Brief Symptom Inventory, the Inventory of Interpersonal Problems and the Social Adjustment Scale. All tests were given at initial, 6- and 12-month assessments. Comprehensive costs were also estimated, and combined with changes in outcomes to examine between-group differences and whether counselling was more cost-effective than standard GP care.
RESULTS: The trial recruited 181 patients. There was an overall significant improvement in the actual scores over time but no difference between groups or between CBT and psychodynamic counselling approaches at either 6 or 12 months. However, fewer experimental group patients were still 'cases' on the BDI than controls. This difference was statistically significant at 12 months and neared significance at 6 months (using logistic regression with the initial score as a covariate). In addition, most patients were very positive about the counselling and considered it helpful. Visual inspection of the outcomes suggested that more patients with mild or moderate depression at study entry had improved and ceased to be cases, and that more of these patients had become 'non-cases' in the experimental than the control group. However, a multiple regression analysis indicated no significant interactions between group and initial severity of depression. This could be partly due to there being no difference in outcome between the experimental and control group patients who were initially severely depressed and few of these patients ceasing to be cases at follow-up. There were no significant differences in the mean total costs, aggregate costs of services, or any of the service-group costs, except for primary care, between the experimental and control groups over time. The cost-burden to GP practices was significantly higher in the experimental than the control group at 6 months.
CONCLUSIONS: Although patients were generally appreciative of the counselling received, there was only limited evidence of improved outcomes in those referred to counselling. Stricter referral criteria to exclude the severely depressed may have yielded more conclusive results. It is also difficult to estimate the effect of recruitment by screening rather than GP referral, which may limit the applicability of the results to routine clinical practice, and may have interfered with the normal working alliance established between the GP, patient and counsellor. A patient preference trial may, therefore, have been more appropriate. The results indicated that there were similar improvements for both CBT and psychodynamic counselling, but a

Entities:  

Mesh:

Year:  2000        PMID: 11134918

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  13 in total

1.  Multiple sclerosis in the UK: service use, costs, quality of life and disability.

Authors:  Paul McCrone; Margaret Heslin; Martin Knapp; Paul Bull; Alan Thompson
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 2.  Counselling for mental health and psychosocial problems in primary care.

Authors:  Peter Bower; Sarah Knowles; Peter A Coventry; Nancy Rowland
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

Review 3.  Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.

Authors:  Marieke Krol; Jocé Papenburg; Marc Koopmanschap; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2011-07       Impact factor: 4.981

4.  Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses.

Authors:  Peter Bower; Sarah Byford; Julie Barber; Jennifer Beecham; Sharon Simpson; Karin Friedli; Roslyn Corney; Michael King; Ian Harvey
Journal:  BMJ       Date:  2003-06-07

Review 5.  On-site mental health workers delivering psychological therapy and psychosocial interventions to patients in primary care: effects on the professional practice of primary care providers.

Authors:  Elaine F Harkness; Peter J Bower
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

Review 6.  The effect of interpersonal psychotherapy and other psychodynamic therapies versus 'treatment as usual' in patients with major depressive disorder.

Authors:  Janus Christian Jakobsen; Jane Lindschou Hansen; Erik Simonsen; Christian Gluud
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

Review 7.  Patients' preferences within randomised trials: systematic review and patient level meta-analysis.

Authors: 
Journal:  BMJ       Date:  2008-10-31

8.  Does receipt of 5As services have implications for patients' satisfaction in India?

Authors:  Divya Persai; Rajmohan Panda; Sudhir Venkatesan; Monika Arora; Jasjit S Ahluwalia
Journal:  BMC Fam Pract       Date:  2014-12-17       Impact factor: 2.497

9.  Feasibility and acceptability of group music therapy vs wait-list control for treatment of patients with long-term depression (the SYNCHRONY trial): study protocol for a randomised controlled trial.

Authors:  Catherine Elizabeth Carr; Julian O'Kelly; Stephen Sandford; Stefan Priebe
Journal:  Trials       Date:  2017-03-29       Impact factor: 2.279

10.  Collaborative Interventions for Circulation and Depression (COINCIDE): study protocol for a cluster randomized controlled trial of collaborative care for depression in people with diabetes and/or coronary heart disease.

Authors:  Peter A Coventry; Karina Lovell; Chris Dickens; Peter Bower; Carolyn Chew-Graham; Andrea Cherrington; Charlotte Garrett; Chris J Gibbons; Clare Baguley; Kate Roughley; Isabel Adeyemi; Chris Keyworth; Waquas Waheed; Mark Hann; Linda Davies; Farheen Jeeva; Chris Roberts; Sarah Knowles; Linda Gask
Journal:  Trials       Date:  2012-08-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.